Literature DB >> 6194468

Cranial computed tomography of 64 children in continuous complete remission of leukemia II: relations to patient data and neurological complications.

U Stephani, G Harten, H J Langermann, H Riehm, F Hanefeld, E Habermalz, H J Habermalz.   

Abstract

Abnormal widening of cortical sulci as seen in posttherapeutic cranial computed tomography (CCT) of 64 children in complete continuous remission (CCR) of acute lymphoblastic leucemia (ALL)/non Hodgkin's lymphoma (NHL) was related to patient data and neurological complications during the application of West Berlin treatment protocol. Age and neurological/neurodevelopmental findings of the patients at diagnosis of their disease positively and significantly correlated with CCT abnormalities. Abnormal pre- and intratherapeutic electroencephalographic (EEG) recordings, the development of a severe polyneuropathy syndrome and/or a considerable loss of weight during treatment were frequently associated with an abnormal widening of cortical sulci. Occurrence of transient early encephalopathy syndrome, development of radiation induced blood brain barrier disturbance and somnolence syndrome were not correlated with these CCT changes. Possible explanations of these abnormalities are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194468     DOI: 10.1055/s-2008-1059568

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  3 in total

1.  Prospective neurophysiological study in children treated for acute lymphoblastic leukaemia: serial EEG during treatment and long-term follow up with evoked potentials.

Authors:  R Korinthenberg; B Igel
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

2.  Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment.

Authors:  L Vainionpää
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

3.  Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia.

Authors:  G Harten; U Stephani; G Henze; H J Langermann; H Riehm; F Hanefeld
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.